Plasminogen activator-1 overexpression decreases experimental postthrombotic vein wall fibrosis by a non-vitronectin-dependent mechanism. - Wikidata - wikimedia - TriplyDB

Plasminogen activator-1 overexpression decreases experimental postthrombotic vein wall fibrosis by a non-vitronectin-dependent mechanism.

Plasminogen activator-1 overexpression decreases experimental postthrombotic vein wall fibrosis by a non-vitronectin-dependent mechanism.

http://www.wikidata.org/entity/Q34021916

about

Libby amphibole‐induced mesothelial cell autoantibodies bind to surface plasminogen and alter collagen matrix remodeling Gram-Negative Pneumonia Alters Large-Vein Cell-Adhesion Molecule Profile and Potentiates Experimental Stasis Venous Thrombosis.TGF-β1 in Vascular Wall Pathology: Unraveling Chronic Venous Insufficiency Pathophysiology.Endotoxaemia-augmented murine venous thrombosis is dependent on TLR-4 and ICAM-1, and potentiated by neutropenia.Divergent effects of Tlr9 deletion in experimental late venous thrombosis resolution and vein wall injury.Venous Thrombosis and Post-Thrombotic Syndrome: From Novel Biomarkers to Biology

P2860

Q29248575-558BBEF0-36E0-48A0-97C3-5FEF3EAA7201 Q40490275-4B9BC9FD-DA03-44A2-B11F-F2C00708DF10 Q48216769-10236E95-9606-4494-98A0-1B3DB5D691BB Q50721291-95FB920E-B826-4C7C-888A-212E48C0DFC3 Q53799532-518AF650-E975-4A56-98C6-B7045EC0CC05 Q58571133-204FCB6D-2A49-4306-920A-F4C2CBAE6C42

P2860

Plasminogen activator-1 overexpression decreases experimental postthrombotic vein wall fibrosis by a non-vitronectin-dependent mechanism.

http://www.wikidata.org/entity/Q34021916

description

2014 nî lūn-bûn

@nan

2014 թուականի Յուլիսին հրատարակուած գիտական յօդուած

@hyw

2014 թվականի հուլիսին հրատարակված գիտական հոդված

@hy

2014年の論文

@ja

2014年論文

@yue

2014年論文

@zh-hant

2014年論文

@zh-hk

2014年論文

@zh-mo

2014年論文

@zh-tw

2014年论文

@wuu

name

Plasminogen activator-1 overex ...... tronectin-dependent mechanism.

@ast

Plasminogen activator-1 overex ...... tronectin-dependent mechanism.

@en

Plasminogen activator-1 overex ...... tronectin-dependent mechanism.

@nl

type

label

Plasminogen activator-1 overex ...... tronectin-dependent mechanism.

@ast

Plasminogen activator-1 overex ...... tronectin-dependent mechanism.

@en

Plasminogen activator-1 overex ...... tronectin-dependent mechanism.

@nl

prefLabel

Plasminogen activator-1 overex ...... tronectin-dependent mechanism.

@ast

Plasminogen activator-1 overex ...... tronectin-dependent mechanism.

@en

Plasminogen activator-1 overex ...... tronectin-dependent mechanism.

@nl

P1433

Q34021916-C52803DE-4F84-45A4-B470-3C1EC40DF250

P1476

Q34021916-28915A1C-06EE-4714-A61E-9EBFD7CCA153

P2093

Q34021916-3E16A089-1FCF-4437-B191-A467D694299A

Q34021916-4843A4E2-A0A0-4156-9C89-BC4B45398B4F

Q34021916-6A3083E9-5DF0-443C-B1EE-A33AB68FA5E3

Q34021916-91395EF5-7648-4173-9C69-C0FCFEE2941A

Q34021916-D806D4FD-71EA-4FB1-BAD1-37BE877D2E0E

Q34021916-EB5BE009-7A24-4CDE-854B-4E39DDA103E0

Q34021916-FFCEEE9C-4A67-4A0C-BC79-B2AA670E1CA1

P2860

Q34021916-02587517-6044-46B9-B30B-C24820A6C8B4

Q34021916-055D1636-1D67-4190-900A-CAC078167A37

Q34021916-08EE9172-BDD2-4C26-B7DF-053193F633F8

Q34021916-0A955AA9-2C17-440F-9EEB-EFD1FB3A154C

Q34021916-11906AA2-301F-4E04-82FA-B3AE7542307C

Q34021916-16A8D9BF-AA29-4744-A1C2-6932D6F219D6

Q34021916-1C884A41-460A-46C5-9E2B-974D30622F52

Q34021916-230AEF5D-B1F8-418B-B892-2AD440057F74

Q34021916-26CE6D07-FD23-4C84-9D79-47D41C107BB2

Q34021916-2737A0B5-E16F-46E0-93B8-34033563C6FE

P304

Q34021916-91491578-6740-424F-9D21-CEE15E79CCB1

P31

Q34021916-26327157-A183-4037-AFC8-962754DBE678

P356

Q34021916-34148DBD-723A-4BDD-897E-F9D028043FA4

P433

Q34021916-A2EF6F7F-0679-4E3E-8FA8-01A76D359CB3

P478

Q34021916-4994933E-3331-44F2-9A1F-6FA4E83EF0E6

P50

Q34021916-4D220974-906F-4FDB-BF75-9CA7B8EEA21C

P577

Q34021916-343468CD-93F5-47DE-B875-0A76E51EEA81

P5875

Q34021916-7C75C51F-B236-4735-9DAE-FD96947A8793

P698

Q34021916-89E9FAC3-5E62-4199-824E-44A50CE93C25

P921

Q34021916-82BCF062-ABCF-4211-A6D3-BC43F47F6F69

P932

Q34021916-0F413A3C-558A-4932-BC6E-AD0278F2DE9C

P356

P1433

Journal of Thrombosis and Haemostasis

P1476

Plasminogen activator-1 overex ...... itronectin-dependent mechanism

@en

P2093

A T Obi

http://www.w3.org/2001/XMLSchema#string

D M Farris

http://www.w3.org/2001/XMLSchema#string

J A Diaz

http://www.w3.org/2001/XMLSchema#string

K J Roelofs

http://www.w3.org/2001/XMLSchema#string

N L Ballard-Lipka

http://www.w3.org/2001/XMLSchema#string

P K Henke

http://www.w3.org/2001/XMLSchema#string

T W Wakefield

http://www.w3.org/2001/XMLSchema#string

P2860

Inhibitory role of plasminogen activator inhibitor-1 in arterial wound healing and neointima formation: a gene targeting and gene transfer study in mice

Antithrombotic therapy for VTE disease: Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines

Macrophage activation and polarization

Endothelial-to-mesenchymal transition contributes to cardiac fibrosis

Vitronectin is not essential for normal mammalian development and fertility.

Bleomycin and IL-1beta-mediated pulmonary fibrosis is IL-17A dependent.

Mouse models of focal arterial and venous thrombosis.

Vitronectin increases vascular permeability by promoting VE-cadherin internalization at cell junctions.

Vitronectin in the cirrhotic liver: an immunomarker of mature fibrosis.

Low-molecular-weight heparin modulates vein wall fibrotic response in a plasminogen activator inhibitor 1-dependent manner.

P304

1353-1363

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1111/JTH.12644

http://www.w3.org/2001/XMLSchema#string

P433

8

http://www.w3.org/2001/XMLSchema#string

P478

12

http://www.w3.org/2001/XMLSchema#string

P50

Daniel A. Lawrence

P577

2014-07-23T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

263294045

http://www.w3.org/2001/XMLSchema#string

P698

24943740

http://www.w3.org/2001/XMLSchema#string

P921

P932

4127110

http://www.w3.org/2001/XMLSchema#string